Advanced search
Publication Cover
Acta Cardiologica Volume 74, 2019 - Issue 5
Submit an article Journal homepage
154
Views
9
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Impact of statin use on high sensitive troponin T levels with moderate exercise

Serkan ÜnlüDepartment of Cardiology, University Hospital of Gazi University, Ankara, Turkey; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6179-8579View further author information
ORCID Icon,
Serdar Gökhan NurkoçDepartment of Cardiology, University Hospital of Gazi University, Ankara, Turkey; View further author information
,
Burak SezenözDepartment of Cardiology, University Hospital of Gazi University, Ankara, Turkey; View further author information
,
Mehmet CingirtDepartment of Medicinal Biochemistry, University Hospital of Gazi University, Ankara, TurkeyView further author information
,
Özlem GülbaharDepartment of Medicinal Biochemistry, University Hospital of Gazi University, Ankara, TurkeyView further author information
&
Adnan AbacıDepartment of Cardiology, University Hospital of Gazi University, Ankara, Turkey; View further author information
Pages 380-385 | Received 17 May 2018, Accepted 03 Aug 2018, Published online: 17 Oct 2018

References

  • Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Nat Rev Cardiol. 2012;9:620–633.
  • Bagai A, Alexander KP, Berger JS, et al. Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis. Am Heart J. 2017;190:135–139.
  • Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. Eur Heart J. 2016;37:267–315.
  • Ford I, Shah ASV, Zhang R, et al. High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol. 2016;68:2719–2728.
  • McKie PM, Heublein DM, Scott CG, et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59:1099–1107.
  • Williams PT, Thompson PD. effects of statin therapy on exercise levels in participants in the national runners’ and walkers’ Health Study. Mayo Clin Proc. 2015;90:1338–1347.
  • Eijsvogels TMH, Shave R, van Dijk A, et al. Exercise-induced cardiac troponin release: real-life clinical confusion. Curr Med Chem. 2011;18:3457–3461.
  • Baker P, Davies SL, Larkin J, et al. Changes to the cardiac biomarkers of non-elite athletes completing the 2009 London Marathon. Emerg Med J. 2013;31:374–379.
  • Regwan S, Hulten EA, Martinho S, et al. Marathon running as a cause of troponin elevation: a systematic review and meta-analysis. J Interv Cardiol. 2010;23:443–450.
  • Parker BA, Augeri AL, Capizzi JA, et al. Effect of statins on creatine kinase levels before and after a marathon run. Am J Cardiol. 2012;109:282–287.
  • Fortescue EB, Shin AY, Greenes DS, et al. Cardiac troponin increases among runners in the boston marathon. Ann Emerg Med. 2007;49:137–143.
  • Jassal D, Moffat D, Krahn J, et al. Cardiac injury markers in non-elite marathon runners. Int J Sports Med. 2009;30:75–79.
  • Shave R, Baggish A, George K, et al. Exercise-induced cardiac troponin elevation. J Am Coll Cardiol. 2010;56:169–176.
  • Shave R, Ross P, Low D, et al. Cardiac troponin I is released following high-intensity short-duration exercise in healthy humans. Int J Cardiol. 2010;145:337–339.
  • Middleton N, George K, Whyte G, et al. Cardiac troponin T release is stimulated by endurance exercise in healthy humans. J Am Coll Cardiol. 2008;52:1813–1814.
  • Eijsvogels TMH, Hoogerwerf MD, Maessen MFH, et al. Predictors of cardiac troponin release after a marathon. J Sci Med Sport. 2015;18:88–92.
  • Jaffe AS, Vasile VC, Milone M, et al. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011;58:1819–1824.
  • Bodor GS, Survant L, Voss EM, et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem. 1997;43:476–484.
  • Ricchiuti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem. 1999;45:2129–2135.
  • Eijsvogels TMH, Hoogerwerf MD, Oudegeest-Sander MH, et al. The impact of exercise intensity on cardiac troponin I release. Int J Cardiol. 2014;171:3–4.
  • Eijsvogels TMH, Januzzi JL, Taylor BA, et al. Impact of statin use on exercise-induced cardiac troponin elevations. Am J Cardiol. 2014;114:624–628.
  • Franklin BA, Lavie CJ. Impact of statins on physical activity and fitness: ally or adversary? Mayo Clin Proc. 2015;90:1314–1319.
  • Vasile VC, Saenger AK, Kroning JM, et al. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:1086–1090.
  • Frankenstein L, Wu AH, Hallermayer K, et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem. 2011;57:1068–1071.
  • Mueller C, Giannitsis E, Christ M, et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med. 2016;68:76–87.e4.
  • Zhelev Z, Hyde C, Youngman E, et al. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis. BMJ 2015;350:h15.
  • Twerenbold R, Badertscher P, Boeddinghaus J, et al. 0/1-hour triage algorithm for myocardial infarction in patients with renal dysfunction. Circulation 2018; 137:436–451.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.